TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19815116

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 11673

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11673
Study: 16729326

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 14592846

Group type: EXPERIMENTAL
Intervention: 900 mg/d vitamin E supplementation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard treatment without vitamin E
Number of subjects: 16
Study: 11724459

Group type: EXPERIMENTAL
Intervention: Long-chain polyunsaturated fatty acids (LC-PUFA) supplementation in formulas for preterm infants
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Long-chain polyunsaturated fatty acids (LC-PUFA) supplementation in formulas for term infants
Number of subjects: 21
Study: 8557123

Group type: EXPERIMENTAL
Intervention: 15-gauge needle
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 17-gauge needle
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 18-gauge needle
Number of subjects: 112
Study: 1585856

Group type: EXPERIMENTAL
Intervention: Exercise testing (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No exercise testing (n = 50)
Number of subjects: 100
Study: 3903504

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg four times daily)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Sulfinpyrazone (200 mg four times daily)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Both aspirin and sulfinpyrazone
Number of subjects: 555
Study: 31375148

Group type: EXPERIMENTAL
Intervention: Condom use advised between diagnosis and follow-up visit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Condom use adherence (per-protocol analysis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Condom use
Number of subjects: 0
Study: 29016878

Group type: EXPERIMENTAL
Intervention: Home Monitoring (HM)
Number of subjects: 1339
Study: 27505210

Group type: EXPERIMENTAL
Intervention: Web-based Attentional Bias Modification (ABM) training, 6 sessions over 2 weeks
Number of subjects: 434

Group type: COMPARATOR
Intervention: Placebo training, 6 sessions over 2 weeks
Number of subjects: 434
Study: 23586449

Group type: EXPERIMENTAL
Intervention: Alcohol (n = 48)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo (n = 48)
Number of subjects: 144

Group type: COMPARATOR
Intervention: No Alcohol (n = 48)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Higher arousal with emotion suppression
Number of subjects: 144
Study: 23167369

Group type: EXPERIMENTAL
Intervention: Cisplatin plus vinorelbine (NP) for 4 cycles
Number of subjects: 451

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 451
Study: 20630944

Group type: EXPERIMENTAL
Intervention: Telmisartan (160 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 18312284

Group type: EXPERIMENTAL
Intervention: Tadalafil
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 100
Study: 16210893

Group type: EXPERIMENTAL
Intervention: EBC collected using R Tube
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: EBC collected using Ecoscreen with added resistance of 5 cm H2O (Res5)
Number of subjects: 23

Group type: COMPARATOR
Intervention: EBC collected using Ecoscreen without added resistance
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Chlorine measurements
Number of subjects: 23
Study: 12436150

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg)
Number of subjects: 10
Study: 10335245

Group type: EXPERIMENTAL
Intervention: Auto-length measurement technique
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Supine measurement technique
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Paper-barrier measurement technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: All techniques
Number of subjects: 48
Study: 8942407

Group type: EXPERIMENTAL
Intervention: High-fat, low-fiber diet
Number of subjects: 43
Study: 8251051

Group type: EXPERIMENTAL
Intervention: Thiamine 3 to 8 g/day administered orally
Number of subjects: 0
Study: 4022687

Group type: EXPERIMENTAL
Intervention: Solution A (90 mmol/L sodium, 20 g/L glucose, bicarbonate)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Solution B (50 mmol/L sodium, 20 g/L glucose, citrate)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Solution C (30 mmol/L sodium, 20 g/L glucose, citrate)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Solution D (30 mmol/L sodium, 50 g/L glucose, citrate)
Number of subjects: 140
Study: 31953863

Group type: EXPERIMENTAL
Intervention: daridorexant 5mg
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: daridorexant 10mg
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: daridorexant 25mg
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: daridorexant 50mg
Number of subjects: 359

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 359

Group type: COMPARATOR
Intervention: zolpidem 10mg
Number of subjects: 359
Study: 30056415

Group type: EXPERIMENTAL
Intervention: Core stability training (3 times/week for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Physical therapy program (Control group)
Number of subjects: 30
Study: 29772132

Group type: EXPERIMENTAL
Intervention: Laser beam on acupuncture points (low power infrared 980 nm, 50 mW laser, 30 seconds at 8,000 Hz, 10 sessions, 3 times per week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simulated laser acupuncture (laser off)
Number of subjects: 0
Study: 24075527

Group type: EXPERIMENTAL
Intervention: Self-controlled feedback (SELF) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinician-controlled feedback (YOKED) group
Number of subjects: 0
Study: 21537491

Group type: EXPERIMENTAL
Intervention: Minimally invasive parathyroidectomy using surgical sonography (MIPUSS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional unilateral open procedure (OP)
Number of subjects: 30
Study: 19528043

Group type: EXPERIMENTAL
Intervention: ED-initiated tobacco control (ETC) consisting of on-site counselling plus up to four telephone booster sessions
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: ETC for unmotivated smokers
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: ETC for ambivalent smokers
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: ETC for motivated smokers
Number of subjects: 1044
Study: 18389608

Group type: EXPERIMENTAL
Intervention: Curation algorithm for chronic gastritis after antihelicobacter therapy
Number of subjects: 0
Study: 15107658

Group type: EXPERIMENTAL
Intervention: Montgomery‐Asberg Depression Rating Scale (MADRS)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Clinical Global Impressions Rating Scale for Severity (CGI‐S)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Hamilton Depression Rating Scale (HAM‐D)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 11530993

Group type: EXPERIMENTAL
Intervention: 10 mg LJP 394 weekly
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 50 mg LJP 394 weekly
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9272319

Group type: EXPERIMENTAL
Intervention: Desmopressin intranasal spray (20 mg)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Desmopressin intranasal spray (40 mg)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Desmopressin intranasal spray
Number of subjects: 65
Study: 8420877

Group type: EXPERIMENTAL
Intervention: Hyperthermia and radiation for superficial tumors
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Hyperthermia and radiation for soft tissue sarcomas
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Hyperthermia and radiation for deep tumors
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Hyperthermia and radiation (general)
Number of subjects: 208
Study: 3091196

Group type: EXPERIMENTAL
Intervention: Lay therapy treatment
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 55
Study: 31652404

Group type: EXPERIMENTAL
Intervention: High fermentable oligo-, di-, monosaccharide, and polyol diet (HFOD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low fermentable oligo-, di-, monosaccharide, and polyol diet (LFOD)
Number of subjects: 18
Study: 29380294

Group type: EXPERIMENTAL
Intervention: 1 mA cathodal tDCS to the left prefrontal cortex
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study: 27334883

Group type: EXPERIMENTAL
Intervention: Preoperative patient education comprising of a video and ICU tour with standard care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard education
Number of subjects: 100
Study: 24613349

Group type: EXPERIMENTAL
Intervention: Atacicept 25 mg
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Atacicept 75 mg
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Atacicept 150 mg
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study: 22844043

Group type: EXPERIMENTAL
Intervention: Resurfacing hip replacement
Number of subjects: 39

Group type: COMPARATOR
Intervention: Total hip replacement (THR)
Number of subjects: 39
Study: 18718884

Group type: EXPERIMENTAL
Intervention: Cognitive remediation using the Neuropsychological Educational Approach to Remediation (NEAR)
Number of subjects: 40
Study: 18257181

Group type: EXPERIMENTAL
Intervention: Monkshood cake‐separated mild‐warm moxibustion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral administration of Xianling Gubao Capsules
Number of subjects: 100
Study: 15926963

Group type: EXPERIMENTAL
Intervention: Expert tele-advice provided to community nurses for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no tele-advice)
Number of subjects: 0
Study: 12825105

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra) 25, 50, or 100 mg
Number of subjects: 71
Study: 10594466

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (MgS) - 12 mmol magnesium lactate daily for 1 month
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 30
Study: 8734750

Group type: EXPERIMENTAL
Intervention: 80 ppm pacing regimen
Number of subjects: 9

Group type: COMPARATOR
Intervention: 50 ppm pacing regimen
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both pacing regimens (80 ppm and 50 ppm)
Number of subjects: 9
Study: 2014850

Group type: EXPERIMENTAL
Intervention: Intravenous ritodrine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral indomethacin
Number of subjects: 40
Study: 6783519

Group type: EXPERIMENTAL
Intervention: Worksite care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 0
Study: 30938842

Group type: EXPERIMENTAL
Intervention: Vortioxetine (10 mg/day for 1 week, then increasing to 20 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vortioxetine and Placebo
Number of subjects: 80
Study: 28779916

Group type: EXPERIMENTAL
Intervention: Korean hand acupressure
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 26860490

Group type: EXPERIMENTAL
Intervention: Combined epidural analgesia with total intravenous anaesthesia (Group E)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (Group C)
Number of subjects: 60
Study: 25618118

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: TIVA
Number of subjects: 80
Study: 22825227

Group type: EXPERIMENTAL
Intervention: Support of in‐pharmacy HIV testing
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Support of in‐pharmacy vaccinations
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Selling syringes to injection drug users (IDUs)
Number of subjects: 480
Study: 19741485

Group type: EXPERIMENTAL
Intervention: Propofol infusion at rates of 10 to 160 mg . kg(‐1). h(‐1)
Number of subjects: 50
Study: 18085142

Group type: EXPERIMENTAL
Intervention: Yuanluo Tongjing needling method
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aricept, 2.5 mg (oral administration)
Number of subjects: 60
Study: 12907440

Group type: EXPERIMENTAL
Intervention: ABVDm (adriamycin, bleomycin, vinblastine, dacarbazine, and methylprednisolone)
Number of subjects: 386

Group type: COMPARATOR
Intervention: EBVMm (epirubicin, bleomycin, vinblastine, methotrexate, and methylprednisolone)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: ABVDm
Number of subjects: 386

Group type: COMPARATOR
Intervention: EBVMm
Number of subjects: 386
Study: 12364843

Group type: EXPERIMENTAL
Intervention: DVP + quetiapine (450 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: DVP + placebo
Number of subjects: 30
Study: 9819796

Group type: EXPERIMENTAL
Intervention: R24 monoclonal antibody (0, 5, 25, 50 mg/m2) with IL-2/α-IFN
Number of subjects: 21

Group type: COMPARATOR
Intervention: IL-2/α-IFN alone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: R24 treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: No R24 treatment (control group)
Number of subjects: 21
Study: 7814822

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 68
Study: 2547304

Group type: EXPERIMENTAL
Intervention: AO (doxorubicin and vincristine) alternating with CMC
Number of subjects: 154

Group type: COMPARATOR
Intervention: AVO (doxorubicin, VP-16, and vincristine) alternating with CMC
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: AO/CMC and AVO/CMC
Number of subjects: 154
Study: 337773

Group type: EXPERIMENTAL
Intervention: elantrine
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: elantrine added to L-dopa treatment
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: elantrine with L-dopa (or Sinemet)
Number of subjects: 111
Study: 30506451

Group type: EXPERIMENTAL
Intervention: Insulin withdrawal
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Insulin therapy after insulin withdrawal
Number of subjects: 9

Group type: COMPARATOR
Intervention: Insulin-controlled euglycaemia (control)
Number of subjects: 9
Study: 28249150

Group type: EXPERIMENTAL
Intervention: Nemolizumab 0.1 mg/kg every 4 weeks
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Nemolizumab 0.5 mg/kg every 4 weeks
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Nemolizumab 2.0 mg/kg every 4 weeks
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Nemolizumab 2.0 mg/kg every 8 weeks
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 26023905

Group type: EXPERIMENTAL
Intervention: SGA infants
Number of subjects: 1948

Group type: COMPARATOR
Intervention: AGA infants
Number of subjects: 1948
Study: 23988464

Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 731

Group type: COMPARATOR
Intervention: Death certificates
Number of subjects: 731
Study: 21195516

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 36
Study: 18309155

Group type: EXPERIMENTAL
Intervention: Chlorthalidone-based antihypertensive regimen
Number of subjects: 4736

Group type: EXPERIMENTAL
Intervention: Stroke during SHEP
Number of subjects: 4736

Group type: EXPERIMENTAL
Intervention: Transient Ischemic Attack (TIA) during SHEP
Number of subjects: 4736
Study: 17176189

Group type: EXPERIMENTAL
Intervention: Cohabitation before engagement
Number of subjects: 197

Group type: COMPARATOR
Intervention: Cohabitation after engagement or not at all
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Relationship adjustment and religiousness
Number of subjects: 197
Study: 14532798

Group type: EXPERIMENTAL
Intervention: Periprostatic infiltration with 10 ml 1% lidocaine
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Entonox (50% nitrous oxide and oxygen) for 2 minutes
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 235
Study: 11281808

Group type: EXPERIMENTAL
Intervention: Parent training in music and multimodal stimulation (1 hour instruction)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Parent training in music and multimodal stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Post-discharge follow-up
Number of subjects: 20
Study: 8986487

Group type: EXPERIMENTAL
Intervention: Continuous zero‐balanced hemofiltration (HF) without dialysis (ultrafiltrate rate 2 l/h)
Number of subjects: 16
Study: 1587033

Group type: EXPERIMENTAL
Intervention: Fingerstall packing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Merocel packing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocortisone-terramycine gauze packs with ventilation tubes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tubes and nasal packing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal patency assessment (peak-flow index and acoustic rhinometry)
Number of subjects: 0
Study: 6145024

Group type: EXPERIMENTAL
Intervention: Aztreonam
Number of subjects: 52

Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Aztreonam (in patients with renal failure or gentamicin-resistant isolates)
Number of subjects: 52
Study: 31425951

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100 μg or 4000 IU daily for 12 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 27619558

Group type: EXPERIMENTAL
Intervention: Combination therapy with gemigliptin 50 mg qd + metformin 1000 to 2000 mg qd
Number of subjects: 433

Group type: COMPARATOR
Intervention: Gemigliptin monotherapy 50 mg qd
Number of subjects: 433

Group type: COMPARATOR
Intervention: Metformin monotherapy 1000 to 2000 mg qd
Number of subjects: 433
Study: 27343309

Group type: EXPERIMENTAL
Intervention: Antagonist protocol
Number of subjects: 622
Study: 24746976

Group type: EXPERIMENTAL
Intervention: ONS-EPA (oral nutritional supplement containing eicosapentaenoic acid)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (isocaloric diet)
Number of subjects: 92
Study: 22854909

Group type: EXPERIMENTAL
Intervention: Kambin triangle approach
Number of subjects: 100

Group type: COMPARATOR
Intervention: Supraneural approach
Number of subjects: 100
Study: 19808454

Group type: EXPERIMENTAL
Intervention: General anesthesia (group 1, 25 patients)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conscious sedation with fentanyl or midazolam (group 2, 25 patients)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: General anesthesia (group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conscious sedation (group 2)
Number of subjects: 50
Study: 17339566

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 611

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 611

Group type: COMPARATOR
Intervention: MT
Number of subjects: 611
Study: 14769080

Group type: EXPERIMENTAL
Intervention: Counterarguing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Undirected thinking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Failed counterarguing
Number of subjects: 0
Study: 11800062

Group type: EXPERIMENTAL
Intervention: Valsartan 80 mg combined with hydrochlorothiazide (HCTZ) 12.5 mg
Number of subjects: 217

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 12.5 mg
Number of subjects: 217

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 25 mg
Number of subjects: 217
Study: 10082603

Group type: EXPERIMENTAL
Intervention: Tissue engineering materials (e.g., Apligraf, Integra)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polymeric wound dressings (e.g., Tegaderm, Opsite)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dermal replacements (e.g., reconstituted collagen and chondroitan sulfate)
Number of subjects: 0
Study: 8151608

Group type: EXPERIMENTAL
Intervention: Ketanserin 40 mg twice daily after six weeks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Ketanserin 40 mg twice daily after ten days
Number of subjects: 13
Study: 3340420

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine injection for myofascial trigger points
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous naloxone (10 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous placebo
Number of subjects: 10
Study: 29650774

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: PRPF31(+/‐) knockout mice
Number of subjects: 0
Study: 27247177

Group type: EXPERIMENTAL
Intervention: Paliperidone Palmitate (PP) 39-234 mg
Number of subjects: 311

Group type: COMPARATOR
Intervention: Haloperidol Decanoate (HD) 25-200 mg
Number of subjects: 311
Study: 25896862

Group type: EXPERIMENTAL
Intervention: MRI-guided treatment strategy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional treatment strategy
Number of subjects: 200
Study: 23193181

Group type: EXPERIMENTAL
Intervention: Resveratrol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21041965

Group type: EXPERIMENTAL
Intervention: Knee exercise group (22 females)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Knee and hip exercise group (23 females)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (25 females, no treatment)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Single-limb single hop test (both intervention groups)
Number of subjects: 70
Study: 17391562

Group type: EXPERIMENTAL
Intervention: Maternal vitamin A (400,000 IU)
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Infant vitamin A (100,000 IU)
Number of subjects: 564

Group type: COMPARATOR
Intervention: Placebo (for both mothers and infants)
Number of subjects: 564
Study: 15536230

Group type: EXPERIMENTAL
Intervention: Topiramate (96 mg/d)
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Topiramate (192 mg/d)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 701
Study: 11437473

Group type: EXPERIMENTAL
Intervention: NN703 (tabimorelin) 1.71 mg/kg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: NN703 (tabimorelin) 3.0 mg/kg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: NN703 (tabimorelin) 4.5 mg/kg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: NN703 (tabimorelin) 6.86 mg/kg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 9541440

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with intraoperative 0.2mg/ml MMC
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with intraoperative 0.4mg/ml MMC
Number of subjects: 28

Group type: COMPARATOR
Intervention: Trabeculectomy alone
Number of subjects: 28